Free Trial

Fox Run Management L.L.C. Makes New Investment in Balchem Co. (NASDAQ:BCPC)

Balchem logo with Basic Materials background
Remove Ads

Fox Run Management L.L.C. acquired a new stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 5,310 shares of the basic materials company's stock, valued at approximately $866,000.

Several other hedge funds have also recently modified their holdings of the stock. Arizona State Retirement System grew its holdings in Balchem by 0.8% in the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock valued at $1,534,000 after purchasing an additional 77 shares during the last quarter. Heritage Family Offices LLP increased its position in Balchem by 8.3% during the fourth quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company's stock worth $231,000 after purchasing an additional 109 shares during the last quarter. Inspire Investing LLC raised its position in shares of Balchem by 4.9% in the 4th quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company's stock worth $401,000 after buying an additional 114 shares during the period. Westside Investment Management Inc. acquired a new position in shares of Balchem in the 3rd quarter valued at about $27,000. Finally, Inspire Advisors LLC increased its position in shares of Balchem by 3.2% in the fourth quarter. Inspire Advisors LLC now owns 5,123 shares of the basic materials company's stock worth $835,000 after acquiring an additional 161 shares in the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. HC Wainwright reiterated a "buy" rating and set a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. Sidoti raised Balchem to a "hold" rating in a research report on Tuesday, February 25th. Finally, StockNews.com lowered Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th.

Remove Ads

Check Out Our Latest Analysis on BCPC

Balchem Stock Down 1.4 %

Shares of BCPC stock traded down $2.32 during trading hours on Friday, hitting $163.79. 151,524 shares of the company were exchanged, compared to its average volume of 122,072. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. The stock has a market capitalization of $5.33 billion, a price-to-earnings ratio of 41.68, a P/E/G ratio of 4.41 and a beta of 0.63. Balchem Co. has a one year low of $137.69 and a one year high of $186.03. The business's 50-day simple moving average is $165.26 and its two-hundred day simple moving average is $169.23.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Sell-side analysts predict that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Profile

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Featured Articles

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Should You Invest $1,000 in Balchem Right Now?

Before you consider Balchem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.

While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads